Showing results (101-110 of 135) with videos related to
Sort By:
Pageof 14
The American Journal of Psychiatry|July 13, 1999
Relationship of awareness of dyskinesia in schizophrenia to insight into mental illnessC Arango, H Adami, J D Sherr, et al.The Journal of Nervous and Mental Disease|January 1, 1989
Diazepam treatment of early symptoms of schizophrenic relapseB Kirkpatrick, R W Buchanan, R W Waltrip, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 16, 2000
Mazindol treatment of negative symptomsW T Carpenter, A Breier, R W Buchanan, et al.The British Journal of Psychiatry : the Journal of Mental Science|April 1, 1976
Evaluating signs and symptoms: comparison of structured interview ans clinical approachesW T Carpenter, M H Sacks, J S Strauss, et al.The American Journal of Psychiatry|June 1, 1995
Patient response and resource management: another view of clozapine treatment of schizophreniaW T Carpenter, R R Conley, R W Buchanan, et al.Psychiatry Research|November 1, 1989
The Schedule for the Deficit syndrome: an instrument for research in schizophreniaB Kirkpatrick, R W Buchanan, P D McKenney, et al.L'Encephale|January 1, 1982
Zinc and copper in patients with schizophreniaJ C Gillin, W T Carpenter, K M Hambidge, et al.Biological Psychiatry|December 1, 1992
Plasma prolactin as a predictor of relapse in drug-free schizophrenic outpatientsB Kirkpatrick, W T Carpenter, K Maeda, et al.Artificial Organs|August 1, 1983
Schizophrenia and dialysisW T Carpenter, J H Sadler, P D Light, et al.Biological Psychiatry|June 1, 1989
Effect of neuroleptic withdrawal on plasma prolactin: a possible marker of receptor adaptationB Kirkpatrick, R W Buchanan, K Maeda, et al.Pageof 14